HFS
AZN icon

Hantz Financial Services’s AstraZeneca AZN Stock Holding History

Hantz Financial Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48M Sell
23,610
-2,624
-10% -$494K 0.06% 204
2026
Q1 		$5.17M Sell
26,234
-35,196
-57% -$6.79M 0.08% 177
2025
Q4 		$11.3M Buy
61,430
+19,622
+47% +$3.44M 0.17% 96
2025
Q3 		$6.42M Buy
41,808
+11,213
+37% +$1.7M 0.1% 184
2025
Q2 		$4.28M Buy
30,595
+6,052
+25% +$848K 0.07% 228
2025
Q1 		$3.61M Buy
24,543
+1,680
+7% +$243K 0.06% 245
2024
Q4 		$3M Buy
22,863
+606
+3% +$84.8K 0.05% 274
2024
Q3 		$3.47M Buy
22,257
+201
+0.9% +$32.4K 0.06% 259
2024
Q2 		$3.44M Sell
22,056
-563
-2% -$84.7K 0.07% 252
2024
Q1 		$3.06M Sell
22,619
-981
-4% -$130K 0.06% 274
2023
Q4 		$3.18M Buy
23,600
+23,493
+21,956% +$3.05M 0.07% 275
2023
Q3 		$14K Hold
107
– – ﹤0.01% 762
2023
Q2 		$15K Sell
107
-84
-44% -$12.4K ﹤0.01% 731
2023
Q1 		$27K Buy
191
+1
+0.5% +$135 ﹤0.01% 676
2022
Q4 		$26K Sell
190
-102
-35% -$12.8K ﹤0.01% 653
2022
Q3 		$32K Buy
292
+73
+33% +$9.26K ﹤0.01% 631
2022
Q2 		$29K Sell
219
-5
-2% -$656 ﹤0.01% 634
2022
Q1 		$30K Sell
224
-11
-5% -$1.32K ﹤0.01% 654
2021
Q4 		$27K Sell
235
-9
-4% -$1.06K ﹤0.01% 599
2021
Q3 		$29K Buy
244
+142
+139% +$16.5K ﹤0.01% 583
2021
Q2 		$12K Hold
102
– – ﹤0.01% 666
2021
Q1 		$10K Sell
102
-21
-17% -$2.11K ﹤0.01% 599
2020
Q4 		$12K Hold
123
– – ﹤0.01% 534
2020
Q3 		$13K Buy
123
+21
+21% +$2.34K ﹤0.01% 491
2020
Q2 		$11K Buy
+102
New +$10.5K ﹤0.01% 472

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hantz Financial Services's AZN Position: Q2 2026 in Review

Hantz Financial Services reduced its AstraZeneca (AZN) stake by 10% in Q2 2026, selling an estimated $494K and leaving 23,610 shares worth $4.48M. The position accounts for 0.06% of the portfolio, ranked #204.

Hantz Financial Services first reported a position in AZN in Q2 2020 and has held it in 25 quarters since. The position peaked at $11.3M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Hantz Financial Services held 23,610 shares of AstraZeneca worth $4.48M as of Q2 2026.
  • Hantz Financial Services sold 2,624 AstraZeneca shares in Q2 2026, an estimated $494K.
  • AstraZeneca made up 0.06% of Hantz Financial Services's portfolio in Q2 2026, its #204 holding.
  • Hantz Financial Services first reported a position in AstraZeneca in Q2 2020 and has held it in 25 quarters since.
  • Hantz Financial Services's AstraZeneca position peaked at $11.3M in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.